Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

Emerging research suggests that certain diabetes medications could offer benefits beyond blood sugar control, potentially ...

While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

The FDA approval of Airsupra permits use for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.

A year ago, he became one of just 200 people selected to take part in the trial of a new asthma treatment, Benralizumab, that ...

LAMAs were largely prescribed for patients in Turkey who had uncontrolled asthma, older age, obesity, exacerbations, and/or ...

Arterial-Blood Studies during Treatment of Severe Refractory Bronchial Asthma in Case 2 on May 17, after Theophylline and Epinephrine (1), at 8:00 A.M., when the Asthma Was Refractory to ...

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that gestational diabetes ...

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

Researchers have unveiled a groundbreaking nasal swab test for diagnosing specific asthma endotypes in children, particularly ...